FdaApplication
ANDA 218231
Identifiers
- fda_app_no: ANDA218231
Properties
| Property | Value |
|---|---|
| applicant_name | NOVUGEN ONCOLOGY SDN BHD |
| application_type | ANDA |
| approval_date | 2024-04-23 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| PAZOPANIB HYDROCHLORIDE | PAZOPANIB HYDROCHLORIDE | EQ 200MG BASE | TABLET;ORAL |
1 product